Last reviewed · How we verify
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
The purpose of this study was to evaluate the safety and efficacy of endoscopic endoloop pre-test for gastroesophageal reflux before anti-reflux surgery or endoscopic treatment. In the study, the investigators used the novel pre-test to narrow the gastric cardia to control symptoms temporarily to decide whether to undergo irreversible surgery or endoscopic treatment.Thirty patients were enrolled and underwent endoscopic endoloop pre-test treatment. The Primary outcome in this study was measured by the percent reduction in post-procedure GERD symptoms as evidenced by analysis of the GERD-HRQL (Health Related Quality of Life) questionnaire. The secondary outcomes included improvement in esophageal 24-hr pH monitoring, improvement in quality of life questionnaires and safety. Patient follow-up assessments were completed at 7 and 14 days post treatment.
Details
| Lead sponsor | Affiliated Hospital to Academy of Military Medical Sciences |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 30 |
| Start date | Thu Feb 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun May 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- GERD
- Reflux Esophagitis
Interventions
- Endoscopic endoloop pre-test treatment
Countries
China